Insider Trading — QuoTrend

WEITZMAN DEBORAH – Insider Transactions

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CAH	WEITZMAN DEBORAH	CEO, PSS Segment	Aug 20 '25	Sale	150.53	21,367	3,216,375	53,428	Aug 20
CAH	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Nov 27 '23	Option Exercise	74.10	27,642	2,048,355	71,844	Nov 29
CAH	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Nov 27 '23	Sale	106.31	36,642	3,895,411	35,202	Nov 29
CAH	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Aug 28 '23	Option Exercise	71.43	6,712	479,438	50,914	Aug 29
CAH	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Aug 28 '23	Sale	89.81	6,712	602,805	44,202	Aug 29